US Patent Issued to UCL Business on July 28 for "Engineered regulatory T cell" (British Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,297, issued on July 28, was assigned to UCL Business Ltd (London).

"Engineered regulatory T cell" was invented by Hans Stauss (London), Sharyn Thomas (London) and Olivier Preham (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an engineered regulatory T cell (Treg) comprising a T cell receptor (TCR) which is capable of specifically binding to a myelin basic protein (MBP) peptide or variant or fragment thereof when the peptide is presented by a major histocompatibility complex (MHC) molecule. The present invention further relates to methods for providing an engineered Treg and to methods and uses of said enginee...